{
    "code": "52026958",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026958",
    "time": "2019-06-28 03:05:24",
    "許可證字號": "衛部藥輸字第026958號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/12\/29",
    "發證日期": "105\/12\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202695804",
    "中文品名": "易擴樂即能322微克乾粉吸入劑",
    "英文品名": "Eklira Genuair 322 micrograms Inhalation Powder",
    "適應症": "適用於慢性阻塞性肺病(COPD)患者之長期維持性支氣管擴張治療。",
    "劑型": "407乾粉吸入劑",
    "包裝": "含劑量計數之吸入器 60劑量塑膠殼裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "Micronised aclidinium bromide",
    "主製造廠": {
        "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
        "申請商地址": "台北市大安區敦化南路二段207號21樓",
        "主製造廠": "",
        "製造廠名稱": "FES0240000  INDUSTRIAS FARMACEUTICAS ALMIRALL, S.A."
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208008910",
            "成分名稱": "Micronised aclidinium bromide",
            "含量描述": "",
            "含量": "0.4000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Eklira Genuair 322mcg-仿單 2017.01.16 (中文)-106-01-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026958&Seq=001&Type=9"
        },
        {
            "title": "Eklira Genuair 322mcg-標籤Label Right 右-106-01-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026958&Seq=003&Type=8"
        }
    ]
}